Ervebo FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 29, 2020.
FDA Approved: Yes (First approved December 19, 2019)
Brand name: Ervebo
Generic name: ebola zaire vaccine, live
Previous name: rVSV∆G-ZEBOV-GP, live attenuated
Dosage form: Injection
Previous Name: V920
Treatment for: Prevention of Ebola Zaire Disease
Ervebo (ebola zaire vaccine, live) is a vaccine indicated for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older.